The thesis
PanicFade v4 is a contrarian mean-reversion strategy built on a simple behavioural premise: negative headline shocks are overreacted to, and prices tend to revert toward fundamentals. It buys large caps hit by sentiment below -0.4 that are already oversold — RSI14 under 35 and trading below their SMA20 — and sizes into the panic. Exits are equally mechanical: it takes reversion (RSI14 above 50 or a reclaim of the SMA20) and hard-stops fresh lows on continued negativity, treating those as a genuine fundamental break rather than noise. The approach is grounded in recent sentiment-feedback literature (arXiv:2509.11970, 2025) and a fixed 24-name universe of liquid mega caps spanning tech, financials, healthcare, staples and energy.
Validation: genuinely encouraging
This is where the strategy earns its keep. Across four walk-forward folds from September 2021 to August 2026, every fold was positive — a meaningful signal given how many contrarian strategies fall apart out of sample. Aggregate out-of-sample return was 21.7% at an OOS Sharpe of 2.44, and the deflated statistics are strong: a Probabilistic Sharpe Ratio of 0.985 and a Deflated Sharpe Ratio of 0.56 across 27 trials. The DSR accounting for multiple testing is the honest number here, and while 0.56 is respectable rather than spectacular, it survives the haircut.
Encouragingly, fold performance improved over time — 1.6% and 3.88% in the choppy 2021–2024 folds, then 10.14% and 21.7% in the two most recent. Whether that reflects a maturing edge or simply a friendlier regime for buying dips is the open question.
Backtest reality check
The headline 37.93% total return sounds large until you annualise it: over 1,233 days that is a 6.79% CAGR at a Sharpe of 0.96 and a 9.3% max drawdown. The win rate is a healthy 62.88% across 530 trades, but turnover is enormous — 5,807% — so the strategy is trading constantly to extract a modest annual return. Fees were only $530 in the model, but real-world slippage on that churn is a live risk the backtest may flatter.
The elephant: it has stopped trading
The most striking datapoint is in the activity log. Across all six scheduled runs from 19 to 26 August 2026, PanicFade v4 executed zero trades and rejected zero — cash and total equity pinned at exactly $10,000. Its entry conditions require a genuine sentiment-plus-oversold coincidence, and in a calm, grinding-higher tape those simply are not firing. That is arguably the strategy behaving correctly; a panic-fader with nothing to fade should wait. But it also means the live book is currently contributing nothing, and the edge only exists in stress that has not arrived.
Verdict
PanicFade v4 is one of the better-validated strategies in the stable — four-for-four folds, strong PSR, disciplined exits. Temper that against a single-digit CAGR, heavy turnover, and a live book that has been dormant for a week. It is a strategy to hold ready for the next drawdown, not one to judge in a quiet market.